Skip to main content
. 2019 Mar 29;27(4):503–508. doi: 10.3727/096504018X15344989701565

Figure 5.

Figure 5

AS-IV inhibits stimulation of the Akt/GSK-3β/β-catenin axis in NSCLC cells. A549 cells were treated with AS-IV (24 ng/ml) for 24 h. (A–D) Representative immunoblots (A), p-AKT (B), p-GSK-3β (C), and p-β-catenin (D) expression in A549 cells. Results are presented as mean ± SEM of three independent experiments. **p < 0.01, compared to the control group.